Cramer Remix: The new supercharged version of Abbvie is worth a buy

In this video

Share

Cramer Remix: The new supercharged version of Abbvie is worth a buy

Jim Cramer breaks down why the Abbvie-Allergan tie-up is a better bet at this level than the Bristol Myers-Celgene combination.
01:08
Fri, Sep 20 20197:37 PM EDT